To include your compound in the COVID-19 Resource Center, submit it here.

Lidakol anti-viral data

LDAKA said preliminary analysis of its double-blind Phase II study showed that mean overall healing time of herpetic lesions in

Read the full 204 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE